Transurethral vaporization of the prostate using 1 470 nm diode laser in treatment of BPH
10.3969/j.issn.1007-1989.2016.12.006
- VernacularTitle:经尿道1470纳米半导体激光汽化术治疗前列腺增生的疗效分析
- Author:
Fayou ZHOU
;
Xiaoyi ZHANG
;
Yunwu WANG
;
Wei XU
;
Shuxian ZHANG
;
Wei PENG
;
Yajun SHEN
;
Yilong WU
;
Jiude ZHENG
;
Pan GAO
- Keywords:
benign prostatic hyperplasia,BPH;
1470 nm;
diode laser;
vaporization
- From:
China Journal of Endoscopy
2016;22(12):26-29
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the efficacy and safety of Transurethral vaporization of the prostate using 1 470 nm diode laser in treatment of BPH.Methods 58 cases BPH patients underwent transurethral vaporization of the prostate using 1 470 nm diode laser from Dec. 2015 to Apr. 2016 were retrospectively analyzed, including the mean operation time and compared hemoglobin, electrolyte, urinary symptoms, before and after surgery.Result Operations were successfully performed in all the 58 cases, with average operation time of (48.2 ± 16.3) min. No difference was found in either hemoglobin decrease or electrolyte decrease before and after surgery. The patients were followed up for 1~3 months, which revealed a signiifcant reduction in IPSS and improvement in Qmaxand PVR (P < 0.05), compared with pre-operation. No severe complications were reported, including transurethral resection (TUR) syndrome, urinary incontinence and impaired erectile function.Conclusion Transurethral vaporization of the prostate using 1 470 nm diode laser is a safe and effective therapy for BPH. It has advantages of short learning curve, very little blood loss, high efifcacy. It has promising broad prospects.